Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma
| Autor: | Fiona A Lynch, Justine Diggens, Mark Shackleton, Haryana M. Dhillon, Hayley Burridge, Maria Ftanou, Lynda J Katona, Jane A. Elliott, Julia Lai-Kwon, Jo Phipps-Nelson, Allan Ben Smith, Victoria Dax, Michael Jefford, Joanne Shaw, Holly Kent, Donna Milne, Alison Button-Sloan, Steve Ellen, Lahiru Russell |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Oncology
medicine.medical_specialty Metastatic melanoma medicine.medical_treatment Psychological intervention fear of cancer recurrence lcsh:Medicine chemical and pharmacologic phenomena Disease Cancer recurrence stepped care Targeted therapy 03 medical and health sciences 0302 clinical medicine Internal medicine Intervention (counseling) Medicine Stepped care 030212 general & internal medicine Uncategorized business.industry lcsh:R General Medicine Immunotherapy 030220 oncology & carcinogenesis business metastatic melanoma |
| Zdroj: | Journal of Clinical Medicine, Vol 9, Iss 2969, p 2969 (2020) Journal of Clinical Medicine Volume 9 Issue 9 |
| ISSN: | 2077-0383 |
| Popis: | Immunotherapies and targeted therapies have revolutionised treatment of metastatic melanoma and improved survival rates. However, survivors treated with novel therapies are vulnerable to high levels of fear of cancer recurrence or progression (FCR). Existing FCR interventions have rarely been trialled in people with advanced cancer. The current study aimed to evaluate the acceptability and feasibility of Fear-Less: a stepped-care model to treat FCR in people with metastatic melanoma treated with immunotherapy or targeted therapy. Sixty-one outpatients with metastatic melanoma were screened using the Fear of Cancer Recurrence Inventory Short Form (FCRI-SF) and Fear of Progression Questionnaire Short Form (FoP-Q-SF). Survivors with subthreshold FCR were stratified to a self-management intervention while those with clinical levels of FCR were provided with an individual therapy, Conquer Fear. Survivor experience surveys and rescreening were administered post-intervention completion. Results indicated that Fear-Less was an acceptable and feasible FCR intervention. Results provided preliminary support for the potential impact of Fear-Less in reducing FCR. Fear-Less is a promising first step in providing an acceptable and feasible stepped-care model to treat FCR in survivors with metastatic disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|